Success Stories: With Our Help and Premium Processing Upgrade, Fellow Physician in Cardiology from India Gets EB1-A Approval in Just 12 Days

 

Client’s Testimonial:

“Thank you!!! This is wonderful news and I truly appreciate your expertise.”

---

On March 9^th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Fellow Physician in the Field of Cardiology (Approval Notice).

---

General Field: Cardiology

Position at the Time of Case Filing: Fellow Physician

Country of Origin: India

State of Residence at the Time of Filing: Georgia

Approval Notice Date: March 9^th, 2022

Processing Time: 12 days (Premium Processing Requested)

---

Case Summary:

The I-140 EB1-A or the Alien of Extraordinary Ability visa is a type of nonimmigrant visa reserved for those extraordinary individuals who can prove their expertise in their area of work. It is only by thus proving their ability that they are granted continued presence on American soil. So, it is evident that this criterion has a thorough vetting process hence requiring a thoroughly prepared petition packet. This is where our team specializes. We help our clients get approvals in the most seamless possible manner.

Our client from India was an M.B.B.S. and worked as a fellow physician in cardiology when he came to us wanting to apply for an EB1-A visa. Our team was quick to find out that he was one of the few leading preventive cardiology experts in cardiology, and he has achieved a consistent and notable record of success and influence in this area of study. We also found that he is especially well-known for his research into the prevention of cardiovascular diseases. Thus, along with these details of his work, we included the following:

• The field has recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 40 times.
• He has actively engaged his peers in the field of cardiology by authoring and co-authoring 48 peer-reviewed scientific articles, 4 letters to the editor, 2 editorials, and two book chapters that have been published in international journals.
• Due to its great applicability in the field, his research in cardiology has been cited 660 times in other peer-reviewed journal articles according to Google Scholar.
• He is in the top 1% of most highly cited authors publishing on topics in Medicine over the past 10 years according to Microsoft Academic.
• We also showed evidence of participation in research work funded by the National Institutes of Health.
• Last but not the least, we used 4 letters of recommendation to support his claim to the category, 2 of which said:

“To counteract cardiovascular disease and save countless lives around the world, preventative research like [the client’s] is essential. [The client’s] research has expanded medical understanding of the predictive power of individual diet and blood lipid levels, two factors that the World Health Organization has identified as health aspects that must be measured early to best prevent the development of serious cardiovascular disease. This verifies the global need for [the client’s] research and the continuation of his efforts.”

“[The client’s] research represents a monumental contribution to cardiovascular disease susceptibility detection via biomarker use, offering a new avenue for risk determination based on circulating progenitor cell counts. Thus, [client’s] work has had a direct beneficial impact on public health in America.”

We were very glad to inform him of the approval when it arrived within just 12 days of filing, thanks to premium processing. We are glad to have had the opportunity to help him in this process.

---